Page last updated: 2024-08-23

tramadol and urea

tramadol has been researched along with urea in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berdat, PA; Carrel, TP; Curatolo, M; Eigenmann, V; Immer, FF; Immer-Bansi, AS; Trachsel, N	1
Best, AE; Duan, WR; Faltynek, CR; Locke, C; Nothaft, W; Othman, AA; Reeh, P; Schaffler, K	1

Trials

2 trial(s) available for tramadol and urea

Article	Year
Pain treatment with a COX-2 inhibitor after coronary artery bypass operation: a randomized trial. The Annals of thoracic surgery, 2003, Volume: 75, Issue:2 Topics: Aged; Analgesics, Opioid; Coronary Artery Bypass; Creatinine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Etodolac; Female; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Pain, Postoperative; Prostaglandin-Endoperoxide Synthases; Tramadol; Urea	2003
An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin. British journal of clinical pharmacology, 2013, Volume: 75, Issue:2 Topics: Administration, Oral; Adult; Analgesics, Opioid; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Evoked Potentials; Hot Temperature; Humans; Indazoles; Lasers, Gas; Male; Pain; Pain Measurement; Pyridines; Severity of Illness Index; Skin; Sulfones; Tramadol; TRPV Cation Channels; Ultraviolet Rays; Urea	2013

Article

Year

Pain treatment with a COX-2 inhibitor after coronary artery bypass operation: a randomized trial.

The Annals of thoracic surgery, 2003, Volume: 75, Issue:2

Topics: Aged; Analgesics, Opioid; Coronary Artery Bypass; Creatinine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Etodolac; Female; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Pain, Postoperative; Prostaglandin-Endoperoxide Synthases; Tramadol; Urea

2003

An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin.

British journal of clinical pharmacology, 2013, Volume: 75, Issue:2

Topics: Administration, Oral; Adult; Analgesics, Opioid; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Evoked Potentials; Hot Temperature; Humans; Indazoles; Lasers, Gas; Male; Pain; Pain Measurement; Pyridines; Severity of Illness Index; Skin; Sulfones; Tramadol; TRPV Cation Channels; Ultraviolet Rays; Urea

2013